Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates

Manfred Schmidt, Denise A. Carbonaro, Carsten Speckmann, Manuela Wissler, John Bohnsack, Melissa Elders, Bruce J. Aronow, Jan Nolta, Donald B. Kohn, Christof Von Kalle

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

A clinical trial of retroviral-mediated transfer of the adenosine deaminase (ADA) gene into umbilical cord blood CD34+ cells was started in 1993. ADA-containing peripheral blood mononuclear cells (PBMCs) have persisted in patients from this trial, with T lymphocytes showing the highest prevalence of gene marking1,2. To gain a greater understanding of the nature and number of the transduced cells that were engrafted, we used linear amplification-mediated PCR (LAM-PCR) to identify clonal vector proviral integrants3,4. In one patient, a single vector integrant was predominant in T lymphocytes at a stable level over most of the eight-year time span analyzed and was also detected in some myeloid samples. T-cell clones with the predominant integrant, isolated after eight years, showed multiple patterns of T-cell receptor (TCR) gene rearrangement, indicating that a single pre-thymic stem or progenitor cell served as the source of the majority of the gene-marked cells over an extended period of time. It is important to distinguish the stable pattern of monoclonal gene marking that we observed here from the progressive increase of a T-cell clone with monoclonal gene marking that results from leukemic transformation, as observed in two subjects in a clinical trial of gene therapy for X-linked severe combined immunodeficiency (SCID)5'6.

Original languageEnglish (US)
Pages (from-to)463-468
Number of pages6
JournalNature Medicine
Volume9
Issue number4
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Gene transfer
Adenosine Deaminase
Fetal Blood
Blood
T-cells
Genes
Newborn Infant
X-Linked Combined Immunodeficiency Diseases
T-Lymphocytes
Blood Cells
Stem Cells
Clone Cells
T-Lymphocyte Gene Rearrangement
Clinical Trials
T-Cell Receptor Genes
Lymphoproliferative Disorders
Gene therapy
Genetic Therapy
T-Cell Antigen Receptor
Cell Count

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Schmidt, M., Carbonaro, D. A., Speckmann, C., Wissler, M., Bohnsack, J., Elders, M., ... Von Kalle, C. (2003). Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nature Medicine, 9(4), 463-468. https://doi.org/10.1038/nm844

Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. / Schmidt, Manfred; Carbonaro, Denise A.; Speckmann, Carsten; Wissler, Manuela; Bohnsack, John; Elders, Melissa; Aronow, Bruce J.; Nolta, Jan; Kohn, Donald B.; Von Kalle, Christof.

In: Nature Medicine, Vol. 9, No. 4, 01.04.2003, p. 463-468.

Research output: Contribution to journalArticle

Schmidt, M, Carbonaro, DA, Speckmann, C, Wissler, M, Bohnsack, J, Elders, M, Aronow, BJ, Nolta, J, Kohn, DB & Von Kalle, C 2003, 'Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates', Nature Medicine, vol. 9, no. 4, pp. 463-468. https://doi.org/10.1038/nm844
Schmidt, Manfred ; Carbonaro, Denise A. ; Speckmann, Carsten ; Wissler, Manuela ; Bohnsack, John ; Elders, Melissa ; Aronow, Bruce J. ; Nolta, Jan ; Kohn, Donald B. ; Von Kalle, Christof. / Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. In: Nature Medicine. 2003 ; Vol. 9, No. 4. pp. 463-468.
@article{2e3169dc63834bf4bdbe31357c630d22,
title = "Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates",
abstract = "A clinical trial of retroviral-mediated transfer of the adenosine deaminase (ADA) gene into umbilical cord blood CD34+ cells was started in 1993. ADA-containing peripheral blood mononuclear cells (PBMCs) have persisted in patients from this trial, with T lymphocytes showing the highest prevalence of gene marking1,2. To gain a greater understanding of the nature and number of the transduced cells that were engrafted, we used linear amplification-mediated PCR (LAM-PCR) to identify clonal vector proviral integrants3,4. In one patient, a single vector integrant was predominant in T lymphocytes at a stable level over most of the eight-year time span analyzed and was also detected in some myeloid samples. T-cell clones with the predominant integrant, isolated after eight years, showed multiple patterns of T-cell receptor (TCR) gene rearrangement, indicating that a single pre-thymic stem or progenitor cell served as the source of the majority of the gene-marked cells over an extended period of time. It is important to distinguish the stable pattern of monoclonal gene marking that we observed here from the progressive increase of a T-cell clone with monoclonal gene marking that results from leukemic transformation, as observed in two subjects in a clinical trial of gene therapy for X-linked severe combined immunodeficiency (SCID)5'6.",
author = "Manfred Schmidt and Carbonaro, {Denise A.} and Carsten Speckmann and Manuela Wissler and John Bohnsack and Melissa Elders and Aronow, {Bruce J.} and Jan Nolta and Kohn, {Donald B.} and {Von Kalle}, Christof",
year = "2003",
month = "4",
day = "1",
doi = "10.1038/nm844",
language = "English (US)",
volume = "9",
pages = "463--468",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates

AU - Schmidt, Manfred

AU - Carbonaro, Denise A.

AU - Speckmann, Carsten

AU - Wissler, Manuela

AU - Bohnsack, John

AU - Elders, Melissa

AU - Aronow, Bruce J.

AU - Nolta, Jan

AU - Kohn, Donald B.

AU - Von Kalle, Christof

PY - 2003/4/1

Y1 - 2003/4/1

N2 - A clinical trial of retroviral-mediated transfer of the adenosine deaminase (ADA) gene into umbilical cord blood CD34+ cells was started in 1993. ADA-containing peripheral blood mononuclear cells (PBMCs) have persisted in patients from this trial, with T lymphocytes showing the highest prevalence of gene marking1,2. To gain a greater understanding of the nature and number of the transduced cells that were engrafted, we used linear amplification-mediated PCR (LAM-PCR) to identify clonal vector proviral integrants3,4. In one patient, a single vector integrant was predominant in T lymphocytes at a stable level over most of the eight-year time span analyzed and was also detected in some myeloid samples. T-cell clones with the predominant integrant, isolated after eight years, showed multiple patterns of T-cell receptor (TCR) gene rearrangement, indicating that a single pre-thymic stem or progenitor cell served as the source of the majority of the gene-marked cells over an extended period of time. It is important to distinguish the stable pattern of monoclonal gene marking that we observed here from the progressive increase of a T-cell clone with monoclonal gene marking that results from leukemic transformation, as observed in two subjects in a clinical trial of gene therapy for X-linked severe combined immunodeficiency (SCID)5'6.

AB - A clinical trial of retroviral-mediated transfer of the adenosine deaminase (ADA) gene into umbilical cord blood CD34+ cells was started in 1993. ADA-containing peripheral blood mononuclear cells (PBMCs) have persisted in patients from this trial, with T lymphocytes showing the highest prevalence of gene marking1,2. To gain a greater understanding of the nature and number of the transduced cells that were engrafted, we used linear amplification-mediated PCR (LAM-PCR) to identify clonal vector proviral integrants3,4. In one patient, a single vector integrant was predominant in T lymphocytes at a stable level over most of the eight-year time span analyzed and was also detected in some myeloid samples. T-cell clones with the predominant integrant, isolated after eight years, showed multiple patterns of T-cell receptor (TCR) gene rearrangement, indicating that a single pre-thymic stem or progenitor cell served as the source of the majority of the gene-marked cells over an extended period of time. It is important to distinguish the stable pattern of monoclonal gene marking that we observed here from the progressive increase of a T-cell clone with monoclonal gene marking that results from leukemic transformation, as observed in two subjects in a clinical trial of gene therapy for X-linked severe combined immunodeficiency (SCID)5'6.

UR - http://www.scopus.com/inward/record.url?scp=0345144017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345144017&partnerID=8YFLogxK

U2 - 10.1038/nm844

DO - 10.1038/nm844

M3 - Article

C2 - 12640448

AN - SCOPUS:0345144017

VL - 9

SP - 463

EP - 468

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 4

ER -